ORPHA:457252
Squamous cell carcinoma of the oral tongue
Also known as: OTSCC · Oral tongue squamous cell carcinoma
Publications
1,838
Trials
3
Interventional, condition-specific
Researchers
1,225
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,838 matched papers (1,351 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
3 matched on ClinicalTrials.gov (2 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,838
1,838 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,838 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,351 in the last 10 years · low confidence
Phrase hits: 1,838 · MeSH hits: 0
Who's working on it?
1,225
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Salo T13 papers · 2026
Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Papers in Europe PMC - 02Li Y9 papers · 2026
Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, China.
Papers in Europe PMC - 03Sun Y7 papers · 2024
State Key Laboratory of Heavy Oil Processing, College of Science, China University of Petroleum, Beijing 102249, China.
Papers in Europe PMC - 04Zhang Y7 papers · 2026
School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong 261021, P.R. China.
Papers in Europe PMC - 05Al-Samadi A6 papers · 2026
Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Papers in Europe PMC - 06Coletta RD6 papers · 2026
Department of Oral Diagnosis, School of Dentistry, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil; Graduate Program in Oral Biology, School of Dentistry, University of Campinas, Piracicaba, São Paulo, Brazil.
Papers in Europe PMC - 07Freitas RA6 papers · 2025
Department of Oral Pathology, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. Electronic address: roseanafreitas@hotmail.com.
Papers in Europe PMC - 08Li S6 papers · 2026
Department of Clinical Medicine, Hangzhou City University School of Medicine, 51 Huzhou Street, Hangzhou, 310015, People's Republic of China.
Papers in Europe PMC - 09Hagström J5 papers · 2026
Department of Pathology, University of Helsinki and Helsinki University Hospital, FI-00014 Helsinki, Finland.
Papers in Europe PMC - 10Liu S5 papers · 2026
Physician, Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China; Physician, Department of Stomatology, Beijing Bo'ai Hospital, China Rehabilitation Research Center, School of Rehabilitation, Capital Medical University, Beijing, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
3
interventional trials for this specific condition
3 interventional trials matched this specific condition name; 2 currently recruiting in our sample.
Data as of 11 September 2026
3 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 86.7th percentile).
low confidence · 86.7th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
3 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06485778·RECRUITING·A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
Not reviewed·Conditions: Oral Tongue Squamous Cell Carcinoma·Matched via name phrase
- NCT07402525·RECRUITING·Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
Not reviewed·Conditions: Oral Tongue Squamous Cell Carcinoma·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 13 · after dedupe 13 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 13 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (13)
- isrctn·ISRCTN18070464·Recruiting·Tongue-preserving treatment using brachytherapy and intensity-modulated radiation therapy technique for localized tongue cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11188227·Recruiting·Prophylactic swallowing exercise protocol in head and neck cancer patients: combination of self-directed and supervised training
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14681287·No longer recruiting·Can we use ultrasound to assess the structure and size of important speech and swallowing muscles before and after radiotherapy ?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13625876·No longer recruiting·A study to assess in-the-moment product liking of a heating device with two variants of an alternative non-tobacco, nicotine-containing consumable in healthy adult heated tobacco product users
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN55168173·No longer recruiting·Testing a potential new treatment for patients with severe alcohol-associated hepatitis called SZN-043
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN63646763·No longer recruiting·A research study to investigate the safety of setanaxib and helpfulness in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17893221·No longer recruiting·Use of light waves to take cross-section pictures of the mouth (optical coherence tomography) in patients with an inflammatory condition that affects mucous membranes inside the mouth (oral lichen planus)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98243550·No longer recruiting·Prophylactic swallowing exercise program in head and neck cancer patients
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17428671·Stopped·NICO - CA209-891: Neoadjuvant and adjuvant nivolumab as Immune Checkpoint inhibition in Oral cavity cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12961998·No longer recruiting·A Dehydroepiandrosterone and Pharmacokinetics in Trauma study (ADaPT)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN62346992·Stopped·Dose escalation study of Olaparib in addition to cisplatin based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13735240·No longer recruiting·A multicentre randomised phase III trial comparing Positron Emission Tomography - computed tomography guided watch and wait policy versus planned NECK dissection for the management of locally advanced (N2/N3) nodal metastases in patients with head and neck squamous cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN89427989·No longer recruiting·A randomised controlled trial of radical radiotherapy alone versus radical surgery plus radical radiotherapy for patients with cancer of the oral cavity
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Squamous cell carcinoma of the oral tongue — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Squamous cell carcinoma of the oral tongue" OR "Squamous cell carcinoma of oral tongue" OR "OTSCC" OR "Oral tongue squamous cell carcinoma"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Squamous cell carcinoma of the oral tongue" OR "Squamous cell carcinoma of oral tongue" OR "OTSCC" OR "Oral tongue squamous cell carcinoma"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 3 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- No Orphanet definition and no Mondo IDs — likely taxonomy scaffolding; confidence capped at low
Ingested 2026-07-27T16:49:34.731Z
